Materials Healthcare Sector

9 Meters Biopharma

Market Cap: US$2.8m

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.

TILT Holdings

Market Cap: CA$3.9m

Provides various cannabis products and services in the United States, Canada, and internationally.

Bod Science

Market Cap: AU$4.3m

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.

Vaccinex

Market Cap: US$2.8m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

Itoco

Market Cap: US$2.8m

Engages in the processing, production, and distribution of medical cannabis products.

Nuformix

Market Cap: UK£2.1m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

Catheter Precision

Market Cap: US$2.8m

Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.

Qualigen Therapeutics

Market Cap: US$2.8m

A clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States.

Awakn Life Sciences

Market Cap: CA$4.0m

A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.

ReShape Lifesciences

Market Cap: US$2.7m

Provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.

Marvel Biosciences

Market Cap: CA$3.8m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Can B

Market Cap: US$2.7m

Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.

IQ-AI

Market Cap: UK£2.0m

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.

Tivic Health Systems

Market Cap: US$2.7m

Operates as a health tech company, develops and commercializes bioelectronic medicine.

NLS Pharmaceutics

Market Cap: US$2.7m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.

Psykey

Market Cap: US$2.7m

Engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.

Scinai Immunotherapeutics

Market Cap: US$2.7m

A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.

Akanda

Market Cap: US$2.6m

Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.

Patrys

Market Cap: AU$4.1m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

Spruce Biosciences

Market Cap: US$2.6m

A biopharmaceutical company, focuses on developing and commercializing novel therapies for neurological disorders.

ValiRx

Market Cap: UK£2.0m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Appili Therapeutics

Market Cap: CA$3.6m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

Megola

Market Cap: US$2.6m

Develops and sells various physical water treatment devices.

Theriva Biologics

Market Cap: US$2.6m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

Psyence Biomedical

Market Cap: US$2.6m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Talis Biomedical

Market Cap: US$2.6m

Operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.

Biotron

Market Cap: AU$4.0m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

Ridder Titan Genesis

Market Cap: US$2.5m

A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.

Venus Concept

Market Cap: US$2.5m

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

Modern Mobility Aids

Market Cap: US$2.5m

Operates in the telehealth and telemedicine industry.

Intelicare Holdings

Market Cap: AU$3.9m

Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

Stem Cell Authority

Market Cap: US$2.4m

A technology development company, focuses on the collection and cryogenic preservation of stem cells.

AXIM Biotechnologies

Market Cap: US$2.4m

Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.

SETO Holdings

Market Cap: US$2.4m

A development stage company, provides healthcare services.

Bone Biologics

Market Cap: US$2.4m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.